Overview

Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The optimal strategy to restore sinus rhythm in patients with atrial fibrillation (AF) of less than 48 hours' duration is still controversial. The investigators performed a controlled single-center trial to compare electrical and pharmacological (propafenone) cardioversion to restore the sinus rhythm in selected patients with acute atrial fibrillation.
Phase:
N/A
Details
Lead Sponsor:
Valduce Hospital
Treatments:
Propafenone